What Is the Place of PARP Inhibitors in Ovarian Cancer Treatment?
Crossref DOI link: https://doi.org/10.1007/s11912-016-0515-z
Published Online: 2016-03-16
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Joyce F.
Matulonis, Ursula A.
Text and Data Mining valid from 2016-03-16